GlobeNewswire Inc.··Aeon BiopharmaAEON Biopharma Appoints CFO With Nearly $1M in Stock Awards as Biosimilar Development Accelerates
AEON Biopharma appoints John Bencich as CFO with 754,717 RSUs and 235,849 PSUs. Company developing ABP-450 biosimilar targeting $3B neurotoxin market.
AEONCFO appointmentinducement awards